Fish odour syndrome with features of both primary and secondary trimethylaminuria

被引:13
作者
Fraser-Andrews, EA
Manning, NJ
Ashton, GHS
Eldridge, P
McGrath, J
Menagé, HD
机构
[1] Univ Hosp Lewisham, Dept Dermatol, London, England
[2] Univ Hosp Lewisham, Dept Biochem, London, England
[3] Sheffield Childrens Hosp, Dept Biochem, Sheffield, S Yorkshire, England
[4] St Thomas Hosp, St Johns Inst Dermatol, Dept Cell Pathol, London, England
关键词
D O I
10.1046/j.1365-2230.2003.01230.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We report a patient with the fish odour syndrome who has both primary and secondary trimethylaminuria. The diagnosis was made using biochemical and genetic analysis in the apparent absence of any characteristic smell. Differentiation of primary and secondary trimethylaminuria is usually made on urinary analysis of trimethylamine and its metabolite trimethylamine N-oxide, with different, characteristic patterns of both compounds in primary and secondary trimethylaminuria. Our patient had biochemical analysis consistent with a diagnosis of secondary trimethylaminuria, while analysis of the flavin-containing mono-oxygenase 3 gene, the causative gene in primary trimethylaminuria, demonstrated three sequence polymorphisms, two of which are known to reduce enzyme activity. The patient showed temporary clinical and biochemical response to treatment with metronidazole and neomycin. It is important to be aware of this diagnosis in patients without obvious clinical signs, and of the subjective benefits of treatment.
引用
收藏
页码:203 / 205
页数:3
相关论文
共 15 条
[1]   Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort [J].
Akerman, BR ;
Lemass, H ;
Chow, LML ;
Lambert, DM ;
Greenberg, C ;
Bibeau, C ;
Mamer, OA ;
Treacy, EP .
MOLECULAR GENETICS AND METABOLISM, 1999, 68 (01) :24-31
[2]   TRIMETHYLAMINURIA - THE DETECTION OF CARRIERS USING A TRIMETHYLAMINE LOAD TEST [J].
ALWAIZ, M ;
AYESH, R ;
MITCHELL, SC ;
IDLE, JR ;
SMITH, RL .
JOURNAL OF INHERITED METABOLIC DISEASE, 1989, 12 (01) :80-85
[3]   THE FISH ODOR SYNDROME - BIOCHEMICAL, FAMILIAL, AND CLINICAL ASPECTS [J].
AYESH, R ;
MITCHELL, SC ;
ZHANG, A ;
SMITH, RL .
BRITISH MEDICAL JOURNAL, 1993, 307 (6905) :655-657
[4]  
Basarab T, 1999, BRIT J DERMATOL, V140, P164
[5]  
Cashman JR, 2000, DRUG METAB DISPOS, V28, P169
[6]   Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome [J].
Dolphin, CT ;
Janmohamed, A ;
Smith, RL ;
Shephard, EA ;
Phillips, IR .
NATURE GENETICS, 1997, 17 (04) :491-494
[7]   Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndrome [J].
Dolphin, CT ;
Janmohamed, A ;
Smith, RL ;
Shephard, EA ;
Phillips, IR .
PHARMACOGENETICS, 2000, 10 (09) :799-807
[8]  
HUMBERT JR, 1970, LANCET, V2, P770
[9]   In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene [J].
Lambert, DM ;
Mamer, OA ;
Akerman, BR ;
Choinière, L ;
Gaudet, D ;
Hamet, P ;
Treacy, EP .
MOLECULAR GENETICS AND METABOLISM, 2001, 73 (03) :224-229
[10]   A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, that causes fish-odour syndrome:: activity of the mutant enzyme assessed by proton NMR spectroscopy [J].
Murphy, HC ;
Dolphin, CT ;
Janmohamed, A ;
Holmes, HC ;
Michelakakis, H ;
Shephard, EA ;
Chalmers, RA ;
Phillips, IR ;
Iles, RA .
PHARMACOGENETICS, 2000, 10 (05) :439-451